Literature DB >> 14550803

Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.

Pieternella S in 't Anker1, Willy A Noort, Alwine B Kruisselbrink, Sicco A Scherjon, Willem Beekhuizen, Roelof Willemze, Humphrey H H Kanhai, Willem E Fibbe.   

Abstract

OBJECTIVE: Previously, we have found that human culture-expanded fetal lung-derived mesenchymal stem cells (MSC) promote the engraftment of umbilical cord blood (UCB)-derived CD34((+)) cells. The high frequency of MSC in fetal lung allowed us to study whether this represented a biological feature of these cells or a property that was acquired during expansion in culture.
MATERIALS AND METHODS: Irradiated NOD/SCID mice (n=80) were transplanted with 0.1x10(6) UCB CD34(+) cells in the presence or absence of 10(6) primary nonexpanded or culture-expanded fetal lung, liver, or BM CD45(-) cells, or with nonexpanded fetal lung liver or BM CD45(-) cells only.
RESULTS: In comparison with transplantation of UCB CD34(+) cells only, cotransplantation of UCB CD34(+) cells and primary fetal lung or BM CD45(-) cells resulted in a significantly higher level of engraftment (% hCD45(+) cells) in BM, PB, and spleen. In addition, primary mesenchymal cells derived from adult BM had a similar promoting effect. The engraftment-enhancing effect was similar to that of culture-expanded fetal lung and BM MSC. Primary mesenchymal cells, but not culture-expanded MSC, were detected in recipient mice, suggesting that the primary cells were able to home and that this capacity was lost after expansion.
CONCLUSIONS: These results show that primary mesenchymal cells from fetal lung and BM promote the engraftment of UCB-derived CD34(+) cells to a similar degree as culture-expanded MSC, indicating that it reflects a biological property of primary MSC that is preserved during expansion in culture.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550803     DOI: 10.1016/s0301-472x(03)00202-9

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  35 in total

1.  Gene therapy for Fanconi anemia: one step closer to the clinic.

Authors:  Jakub Tolar; Pamela S Becker; D Wade Clapp; Helmut Hanenberg; Cristina Díaz de Heredia; Hans-Peter Kiem; Susana Navarro; Pankaj Qasba; Paula Rio; Manfred Schmidt; Julián Sevilla; Els Verhoeyen; Adrian J Thrasher; Juan Bueren
Journal:  Hum Gene Ther       Date:  2012-02       Impact factor: 5.695

2.  No Synergistic Effect of Cotransplantation of MSC and Ex Vivo TPO-Expanded CD34(+) Cord Blood Cells on Platelet Recovery and Bone Marrow Engraftment in NOD SCID Mice.

Authors:  Mark van der Garde; Anneke Brand; Manon C Slot; Alice de Graaf-Dijkstra; Jaap Jan Zwaginga; Yvette van Hensbergen
Journal:  Stem Cells Dev       Date:  2015-03-13       Impact factor: 3.272

Review 3.  Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation.

Authors:  Charalampos Pontikoglou; Frédéric Deschaseaux; Luc Sensebé; Helen A Papadaki
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

Review 4.  Concise review: hitting the right spot with mesenchymal stromal cells.

Authors:  Jakub Tolar; Katarina Le Blanc; Armand Keating; Bruce R Blazar
Journal:  Stem Cells       Date:  2010-08       Impact factor: 6.277

Review 5.  Concise review: adult multipotent stromal cells and cancer: risk or benefit?

Authors:  Gwendal Lazennec; Christian Jorgensen
Journal:  Stem Cells       Date:  2008-04-03       Impact factor: 6.277

6.  Co-transplantation of human mesenchymal stem cells promotes human CD34+ cells engraftment in a dose-dependent fashion in NOD/SCID mice.

Authors:  Seong-Kyu Park; Jong-Ho Won; Hyun-Jung Kim; Sang-Byung Bae; Chan-Kyu Kim; Kyu-Taeg Lee; Nam-Su Lee; You Kyoung Lee; Dae-Chul Jeong; Nak-Gyun Chung; Hyun-Soo Kim; Dae-Sik Hong; Hee-Sook Park
Journal:  J Korean Med Sci       Date:  2007-06       Impact factor: 2.153

7.  Activin A expression regulates multipotency of mesenchymal progenitor cells.

Authors:  Farida Djouad; Wesley M Jackson; Brent E Bobick; Sasa Janjanin; Yingjie Song; George T J Huang; Rocky S Tuan
Journal:  Stem Cell Res Ther       Date:  2010-05-04       Impact factor: 6.832

8.  Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID-repopulating cells and committed progenitor cells of B lymphoid and myeloid lineages.

Authors:  Alexandra Briquet; Sophie Dubois; Sandrine Bekaert; Marie Dolhet; Yves Beguin; André Gothot
Journal:  Haematologica       Date:  2009-08-27       Impact factor: 9.941

9.  Generation of tissue-specific cells from MSC does not require fusion or donor-to-host mitochondrial/membrane transfer.

Authors:  Evan J Colletti; Judith A Airey; Wansheng Liu; Paul J Simmons; Esmail D Zanjani; Christopher D Porada; Graça Almeida-Porada
Journal:  Stem Cell Res       Date:  2008-09-16       Impact factor: 2.020

10.  Allogeneic non-adherent bone marrow cells facilitate hematopoietic recovery but do not lead to allogeneic engraftment.

Authors:  Stephan Fricke; Manuela Ackermann; Alexandra Stolzing; Christoph Schimmelpfennig; Nadja Hilger; Jutta Jahns; Guido Hildebrandt; Frank Emmrich; Peter Ruschpler; Claudia Pösel; Manja Kamprad; Ulrich Sack
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.